Generated by All in One SEO Pro v4.9.10, this is an llms.txt file, used by LLMs to index the site.

# Elegen

Elegen is powering the bioeconomy with high-accuracy DNA synthesis that delivers industry-leading speed, length, and quality.

## Sitemaps

- [XML Sitemap](https://elegenbio.com/sitemap.xml): Contains all public & indexable URLs for this website.

## Posts

- [pET24_XhoI_BamHI-Kan Standard Vector Info Sheet](https://elegenbio.com/pet24_xhoi_bamhi-kan-standard-vector-info-sheet/) - Standard vector info sheet, including key features, sequence data and diagram.
- [Whitepaper - Error Quantification Method](https://elegenbio.com/whitepaper-error-quantification-method/) - Methodology and results from error rate quantification for ENFINIA Linear DNA by Elegen.
- [pET17-NdeI_XhoI-Amp Standard Vector Info Sheet](https://elegenbio.com/pet17-ndei_xhoi-amp-standard-vector-info-sheet/) - pBR322-AMP Standard vector info sheet, including key features, sequence data and diagram.
- [ENFINIA™ Linear DNA Amplification and Cloning Guide](https://elegenbio.com/amplification-and-cloning-guide-2/) - Recommendations for amplification and cloning ENFINIA Linear DNA, such as resuspending DNA in molecular grade water or TE buffer.
- [pET28 EcoRI HindIII Standard Vector Info Sheet](https://elegenbio.com/pet28-ecori-hindiii-standard-vector-info-sheet/) - pET28 EcoRI HindIII Standard Vector Info Sheet
- [ENFINIA™ DNA Cloning and Amplification User Guide](https://elegenbio.com/enfinia-dna-cloning-and-amplification-user-guide/) - User Guide for ENFINIA™ IVT Ready DNA resuspension, storage, cloning and amplification.
- [ZZ-Strep-pNUC-Kann Standard Vector Info Sheet](https://elegenbio.com/zz-strep-pnuc-kann-standard-vector-info-sheet/) - pBR322-AMP Standard vector info sheet, including key features, sequence data and diagram.
- [TRX-Strep-pNUC-Kan Standard Vector Info Sheet](https://elegenbio.com/trx-strep-pnuc-kan-standard-vector-info-sheet/) - pBR322-AMP Standard vector info sheet, including key features, sequence data and diagram.
- [SUMO-Strep-pNUC-Kan Standard Vector Info Sheet](https://elegenbio.com/sumo-strep-pnuc-kan-standard-vector-info-sheet/) - pBR322-AMP Standard vector info sheet, including key features, sequence data and diagram.
- [SNUT-Strep-pNUC-Kan Standard Vector Info Sheet](https://elegenbio.com/snut-strep-pnuc-kan-standard-vector-info-sheet/) - pBR322-AMP Standard vector info sheet, including key features, sequence data and diagram.
- [pUC19-NoEcoRI-Amp Standard Vector Info Sheet](https://elegenbio.com/puc19-noecori-amp-standard-vector-info-sheet/) - pBR322-AMP Standard vector info sheet, including key features, sequence data and diagram.
- [psaRNA_CleanCap-Amp Standard Vector Info Sheet](https://elegenbio.com/psarna_cleancap-amp-standard-vector-info-sheet-2/) - pBR322-AMP Standard vector info sheet, including key features, sequence data and diagram.
- [FH8-Strep-pNUC-Kan Standard Vector Info Sheet](https://elegenbio.com/h8-strep-pnuc-kan-standard-vector-info-sheet-2/) - pBR322-AMP Standard vector info sheet, including key features, sequence data and diagram.
- [P17-Strep-pNUC-Kan Standard Vector Info Sheet](https://elegenbio.com/p17-strep-pnuc-kan-standard-vector-info-sheet/) - pBR322-AMP Standard vector info sheet, including key features, sequence data and diagram.
- [CUSF-Strep-pNUC-Kan Standard Vector Info Sheet](https://elegenbio.com/cusf-strep-pnuc-kan-standard-vector-info-sheet/) - pBR322-AMP Standard vector info sheet, including key features, sequence data and diagram.
- [pAAV2-CAG-AMP Standard Vector Info Sheet](https://elegenbio.com/paav2-cag-amp-standard-vector-info-sheet-2/) - pAAV2-CAG-AMP Standard Vector Info Sheet
- [High-Quality Templates for Improved mRNA Yield and Purity](https://elegenbio.com/high-quality-templates-for-improved-mrna-yield-and-purity/) - Learn how ready-use linear templates can accelerate mRNA vaccine development with the same purity and yield as traditional plasmids.
- [High Quality mRNA Production Using ENFINIA™ IVT Ready DNA with NEB’s HiScribe T7 mRNA Kit](https://elegenbio.com/high-quality-mrna-production-using-enfinia-ivt-ready-dna-with-nebs-hiscribe-t7-mrna-kit/) - ENFINIA™ IVT Ready DNA is a superior and more cost-effective alternative to plasmid-derived DNA for mRNA synthesis using New England Biolabs (NEB)'s HiScribe® T7 mRNA Kit. ENFINIA IVT Ready DNA is a linear double-stranded template with an encoded poly(A) tail, enabling rapid, reliable mRNA production without the need for cloning, purification, linearization, or amplification steps typical of plasmid-based approaches
- [Application Note: Validation of ENFINIA Plasmid DNA Production](https://elegenbio.com/validation-of-enfinia-plasmid-dna-production/) - The study demonstrates how Elegen can reliably produce sequence-perfect plasmids, while achieving over a 92% success rate with a ship time as fast as 10 business days.
- [Flyer - IVT Ready DNA - Exceptional Tail Quality](https://elegenbio.com/flyer-ivt-ready-dna-exceptional-tail-quality/) - Learn about the exceptionally high quality you can expect from every NGS-verified sequence of ENFINIA IVT Ready DNA.
- [ENFINIA™ Linear DNA Specifications and Submission Guidelines](https://elegenbio.com/specifications-and-submission-guidelines/) - Sequence submission acceptance criteria for ENFINIA™ Linear DNA
- [ENFINA Plasmid DNA Specifications and Submission Guidelines](https://elegenbio.com/enfina-plasmid-dna-specifications-and-submission-guidelines-2/) - Sequence submission acceptance criteria for ENFINIA™ Plasmid DNA
- [ENFINIA™ IVT Ready DNA Specifications and Submission Guidelines](https://elegenbio.com/enfinia-ivt-ready-dna-specifications-and-submission-guidelines/) - Sequence submission acceptance criteria for ENFINIA™ Linear DNA
- [Download - Introduction to ENFINIA™ Linear DNA Flyer](https://elegenbio.com/download-introduction-to-enfinia-linear-dna-flyer-2/) - Introducing the next generation of DNA synthesis. Learn how our innovation in cell free synthesis can help advance your research.
- [eBook - GEN - Next-Gen Gene Synthesis Using Cell-Free Cloning](https://elegenbio.com/ebook-gen-next-gen-gene-synthesis-using-cell-free-cloning-2/) - In this eBook published by GEN, explore the cutting-edge world of mRNA technology and its potential to revolutionize medicine, powered by cell-free cloning.
- [Application Note: Accelerated CRISPR-Cas Characterization with ENFINIA Linear DNA Templates and Cell-Free TXTL](https://elegenbio.com/application-note-accelerated-crispr-cas-characterization-with-enfinia-linear-dna-templates-and-cell-free-txtl-2/) - This application note demonstrates the capability of cell-free linear DNA in CRISPR gene editing applications that typically require plasmid DNA.
- [Download DDW In Focus eReport - Cell Therapy (beyond CAR-T) and Opportunities for New Medicines](https://elegenbio.com/download-ddw-in-focus-ereport-cell-therapy-beyond-car-t-and-opportunities-for-new-medicines/) - Presented by Drug Discovery World, this eReport explores the cell therapy market and its expected significant growth in the next five years. Download now to gain an understanding of the current market and the areas of greatest commercial potential for the future.
- [DNA Buyer's Guide - Next Generation Cell-Free Synthesis](https://elegenbio.com/dna-buyers-guide-next-generation-cell-free-synthesis/) - Download the guide for a detailed comparison of industry-leading gene synthesis vendors, comparing key metrics (error rate, turnaround time, cost, and length). Learn the fundamentals of synthetic genetics and key advancements in the industry.
- [Poster – DDN – Turbocharging mRNA Template Development](https://elegenbio.com/poster-ddn-turbocharging-mrna-template-development/) - In this DDN infographic, learn how advanced cell-free gene synthesis technology offers a rapid, reliable way to expedite mRNA synthesis and lifesaving vaccine and therapy development.
- [Download - mRNA Poster](https://elegenbio.com/download-mrna-poster/) - Poster presented at the 2025 mRNA Summit in Boston, July 23, 2025. Learn how Elegen's cell-free, high-fidelity linear double-stranded DNA (dsDNA) provides a faster, scalable alternative to plasmid-derived DNA templates for mRNA production.
- [Flyer - How We Make 7kb in 6 Days](https://elegenbio.com/download-how-we-make-7kb-in-6-days/) - Learn how Elegen creates linear DNA up to 7kb in length in 6 business days without conventional cell-based cloning, using patented cell-free cloning technology.
- [Application Note - Rapid Cell-Free Protein Expression with ENFINIA™ Linear DNA](https://elegenbio.com/application-note-rapid-cell-free-protein-expression-with-enfinia-linear-dna-2/) - This application note demonstrates that ENFINIA Linear DNA performs comparably to plasmid DNA in the myTXTL Pro Cell-Free Expression Kit from Daicel Arbor Biosciences.
- [Application Note: Using ENFINIA™ Linear DNA in Gibson Assembly Reactions](https://elegenbio.com/application-note-using-enfinia-linear-dna-in-gibson-assembly-reactions-2/) - Learn how ENFINIA™ Linear DNA can be used directly in Gibson Assembly reactions without prior adapter removal, reducing time and cost.
- [Application Note: Rapid Clonal Gene Synthesis of Long, Complex Biosynthetic Pathways](https://elegenbio.com/application-note-rapid-clonal-gene-synthesis-of-long-complex-biosynthetic-pathways-2/) - We demonstrate the advantages of ENFINIA Plasmid DNA using the β-carotene and lycopene biosynthetic pathways to assemble and clone complex sequences.
- [Application Note: Minimizing the Risk of Impurities Derived from PCR](https://elegenbio.com/application-note-minimizing-the-risk-of-impurities-derived-from-pcr-2/) - A comparative study between two synthetic gene fragment providers. The results demonstrate ENFINIA™ DNA ability to generate a purer PCR product in comparison to the sequences from Supplier A.
- [Whitepaper - ENFINIA IVT Ready DNA - Cell-Free Linear DNA Templates for mRNA Synthesis](https://elegenbio.com/whitepaper-enfinia-ivt-ready-dna-cell-free-linear-dna-templates-for-mrna-synthesis/) - This study compares ENFINIA IVT Ready DNA to linearized plasmid DNA as templates for IVT by evaluating template quality, resulting mRNA yield and quality, and the expression level of transcribed eGFP in HeLa mammalian cells.
- [ENFINIA™ IVT Ready DNA : Frequently Asked Questions](https://elegenbio.com/enfinia-ivt-ready-dna-frequently-asked-questions/) - Commonly asked questions regarding ordering ENFINIA DNA, such as DNA sequence limitations, per-base cost, minimum order size, and how to order.
- [Flyer - ENFINIA™ IVT Ready Scale Up Option](https://elegenbio.com/flyer-enfinia-ivt-ready-scale-up-option/) - Unlock larger 50 µg yields for select customers who meet minimum purchase requirements.
- [ENFINIA™ IVT Ready DNA User Guide](https://elegenbio.com/enfinia-ivt-ready-dna-user-guide/) - User Guide for ENFINIA™ IVT Ready DNA
- [Whitepaper - ENFINIA™ IVT Ready DNA Internal Data](https://elegenbio.com/whitepaper-enfinia-ivt-ready-dna-internal-data/) - A study comparing a novel cell-free DNA synthesis platform, ENFINIA™ IVT Ready DNA, with conventional linearized plasmid templates for the production of mRNA
- [ENFINIA™ Plasmid DNA - Frequently asked questions](https://elegenbio.com/enfinia-plasmid-faq/) - Frequently asked questions for ENFINIA Plasmid DNA, including ordering instructions, as well as available prep, yield, and cloning vectors.
- [ENFINIA™ DNA 2025 Pricing Update](https://elegenbio.com/enfinia-dna-2025-pricing-update-2/) - Elegen announces new pricing across ENFINIA DNA products, now as low as $0.15 per base pair. The price reduction allows researchers to screen, optimize, and gain insights faster
- [Ordering ENFINIA™ DNA : Frequently Asked Questions](https://elegenbio.com/ordering-enfinia-dna-frequently-asked-questions-2/) - Commonly asked questions regarding ordering ENFINIA DNA, such as DNA sequence limitations, per-base cost, minimum order size, and how to order.
- [ENFINIA™ Linear DNA High Yield Linear Synthesis Options](https://elegenbio.com/high-yield-linear-synthesis-options-2/) - High yield synthesis options for ENFINIA Linear DNA. Each sequence synthesized is NGS-verified before shipment
- [pcDNA3.1  Standard Vector Info Sheet​](https://elegenbio.com/pcdna3-1-standard-vector-info-sheet-pst/) - pcDNA3.1 Standard Vector Info Sheet​
- [pUC19-AMP Standard Vector Info Sheet](https://elegenbio.com/puc19-amp-standard-vector-info-sheet-2/) - pUC19-AMP Standard Vector Info Sheet
- [pAAV2-CMV-AMP Standard Vector Info Sheet](https://elegenbio.com/paav2-cmv-amp-standard-vector-info-sheet-2/) - pAAV2-CMV-AMP Standard vector info sheet, including key features, sequence data and diagram.
- [pAAV2-hSyn-AMP Standard Vector Info Sheet](https://elegenbio.com/paav2-hsyn-amp-standard-vector-info-sheet-2/) - pAAV2-hSyn-AMP Standard vector info sheet, including key features, sequence data and diagram.
- [psaRNA-AMP Standard Vector Info Sheet](https://elegenbio.com/psarna-amp-standard-vector-info-sheet-2/) - psaRNA-AMP Standard Vector Info Sheet
- [pAAV2-AMP Standard Vector Info Sheet​](https://elegenbio.com/paav2-amp-standard-vector-info-sheet/) - pAAV2-AMP Standard Vector Info Sheet​
- [pBR322-AMP Standard Vector Info Sheet](https://elegenbio.com/pbr322-amp-standard-vector-info-sheet-2/) - pBR322-AMP Standard vector info sheet, including key features, sequence data and diagram.

## Pages

- [ENFINIA™  DNA from Elegen - Cell Free Clonal Gene Synthesis](https://elegenbio.com/) - Skip cloning with the only entirely cell-free DNA synthesis provider. Sequences up to 7 kb. Error rates as low as 1:70,000/bp. Manufactured in USA, NGS-verified and shipped globally in as few business days.
- [ENFINIA™ IVT Ready DNA](https://elegenbio.com/products/enfinia-ivt-ready-dna/) - ENFINIA™ Linear DNA from Elegen. Ready-use mRNA template DNA synthesis. US Made, NGS-verified. No Cloning, No Compromises.
- [ENFINIA™ Linear DNA](https://elegenbio.com/products/enfinia-linear-dna/) - ENFINIA™ Linear DNA from Elegen. A NEW CLASS OF DNA. Streamline workflows with long and complex DNA synthesis that does not compromise on accuracy. No Cloning. US Made, NGS-verified.
- [How We Compare](https://elegenbio.com/products/how-we-compare/) - Submit a competitor's quote to see if Elegen can beat their price.
- [Products](https://elegenbio.com/products/) - Elegen offers a full suite of ready-use Linear and Plasmid DNA synthesis with industry leading length, accuracy, and fast turnaround time.
- [Quality Control for ENFINIA™ DNA](https://elegenbio.com/technology/quality-control-for-enfinia-dna/) - Every ENFINIA sequence—whether Linear DNA, IVT-Ready DNA, or Plasmid DNA—undergoes a stringent quality control protocol before shipping. We evaluate every construct across three critical dimensions and NGS-verify every sequence regardless of length or format, so you can proceed with confidence knowing that the DNA you receive is the sequence you designed.
- [The High Accuracy of Elegen Linear DNA](https://elegenbio.com/technology/the-high-accuracy-of-elegen-linear-dna/) - Learn how Elegen's ENFINIA Linear DNA achieves 99.999% per-base accuracy. For a standard complexity 3 kb construct, approximately 96% of molecules are sequence-perfect, allowing constructs to be used immediately upon arrival—without the need for cloning or colony screening.
- [Cell-Free Gene Synthesis](https://elegenbio.com/technology/cell-free-gene-synthesis/) - High-Speed, Sequence-Perfect DNA Generation at Scale. Elegen’s patented DNA synthesis platform delivers long, sequence-perfect DNA without the biological constraints of bacteria. By eliminating E. coli from the workflow, we bypass the laborious, multi-day cloning steps that bottleneck traditional synthetic biology.
- [Introducing the GEN II Cell Free DNA Production Platform](https://elegenbio.com/technology/gen-ii-cell-free-dna-production-platform/) - Elegen's proprietary automated microfluidic process allows for higher throughput, lower costs, higher accuracy and more efficiency per foundry square foot.
- [High Throughput Microfluidic Oligonucleotide Synthesis](https://elegenbio.com/technology/high-throughput-microfluidic-oligonucleotide-synthesis/) - Elegen's proprietary microfluidic synthesizer produces short oligos with high purity, using less space due to our miniaturized, patented process. Our synthesizer allows for higher throughput, lower costs, higher accuracy and more efficiency per foundry square foot.
- [Technology](https://elegenbio.com/technology/) - Elegen's proprietary automated microfluidic process allows for higher throughput, higher accuracy and more efficiency per foundry square foot.
- [News](https://elegenbio.com/news/) - Learn how Elegen is innovating programmable biology with faster, higher quality gene synthesis. Read the latest press and news about Elegen and ENFINIA DNA Products.
- [Videos](https://elegenbio.com/resources/videos/) - Watch Elegen's latest videos and learn more about the advancements of our cell-free DNA synthesis technology and full suite of ready-use products.
- [Case Study: Streamlining mRNA Synthesis with Base RNA Facility](https://elegenbio.com/resources/case-studies/case-study-streamlining-mrna-synthesis-with-base-rna-facility/) - This comprehensive case study demonstrates how Elegen’s ENFINIA™ IVT Ready DNA delivers a streamlined, ready-to-use solution for in vitro transcription (IVT) . By using linear DNA templates with pre-encoded poly(A) tails, researchers can entirely bypass traditional PCR tailing steps and significantly shorten experimental timelines .
- [Case Studies](https://elegenbio.com/resources/case-studies/) - Learn more about how our customers are using ENFINIA DNA to accelerate their research.
- [Cell and Gene Therapy, and Genome Editing](https://elegenbio.com/applications/cell-and-gene-therapy-and-genome-editing/) - ENFINIA DNA offers versatility for cell and gene therapy and gene editing with industry-leading speed, NGS-verified fidelity, reliability, and affordability in both linear and plasmid formats. The platform’s ability to produce high-complexity sequences allows for the construction of safe, tailored, and more effective personalized therapeutic payloads without compromising on speed.
- [Protein Expression](https://elegenbio.com/applications/protein-expression/) - Conventional protein expression workflows are limited by the rate at which cells grow. Eliminate this bottleneck with cell-free ENFINIA Linear DNA and cell-free protein expression.
- [Events](https://elegenbio.com/company/events/) - Events Visit us at our upcoming events May 11-15, 2026 PEGS Summit Boston Boston, MA A premier biotechechnology conference focused on protein and antibody engineering. For over 20 years, it has united global experts to discuss immunotherapy, oncology, and drug delivery. The 2026 event features 350+ speakers and 20 tracks, emphasizing AI/ML-driven research and emerging
- [Careers](https://elegenbio.com/careers/)
- [Applications](https://elegenbio.com/applications/) - ENFINIA™ Linear and Plasmid DNA offer direct-use, high purity gene synthesis for vaccine development, cell and gene therapies and protein expression.
- [Literature](https://elegenbio.com/resources/literature/) - Literature View and download our content Learn More about ENFINIA™ DNA Synthesis ENFINIA™ DNA - A New Class of DNA Read more Introduction to ENFINIA Linear DNA Read more High Complexity Synthesis Read more Product Documentation and Content Library TitleProductContent TypeExcerptPreview Whitepaper - Error Quantification MethodENFINIA™ Linear DNAWhitepaperMethodology and results from error rate quantification for
- [Watch Video - GEN II Launch - Next Level Cell Free DNA Synthesis](https://elegenbio.com/resources/videos/watch-video-gen-ii-launch-next-level-cell-free-dna-synthesis/) - In this GEN webinar, DNA synthesis experts Michael Junkin, PhD, and Brittany Enzmann, PhD, will provide an exclusive first look at Elegen’s GEN II Cell-Free DNA production platform that combines Elegen’s patented split-pool microfluidic synthesizer and cell-free cloning technology. Learn how the platform utilizes AI and robotics to fully automate the production of long, high-complexity, clonal-quality DNA—eliminating the need for bacterial cells and delivering high accuracy gene synthesis at a lower cost.
- [mRNA Personalized Cancer Vaccines](https://elegenbio.com/applications/mrna-personalized-cancer-vaccines/) - Discover how Elegen helps eliminate bottlenecks in mRNA personalized cancer vaccine development with ENFINIA IVT Ready DNA, delivered in days.
- [Microfluidic Cell Free Synthesis](https://elegenbio.com/technology/microfluidic-cell-free-synthesis/) - Elegen's proprietary automated microfluidic process allows for higher throughput, lower costs, higher accuracy and more efficiency per foundry square foot.
- [GEN II Pricing Announcement](https://elegenbio.com/technology/gen-ii-pricing-announcement/) - Announcing early access to lower pricing via our new GEN II synthesizer, which promises faster and more efficient synthesis and lower costs.
- [Elegen Raises the Bar for Synthetic DNA by Lowering Prices Across Its ENFINIA™](https://elegenbio.com/news/2026-pricing-reduction-announcement-pr/) - Elegen, a leader in next-generation cell-free DNA manufacturing, today announced broad price reductions across its ENFINIA™ DNA portfolio, made possible by the transition of its GEN II Cell-Free DNA Platform into full commercial production.
- [mRNA Prophylactic Vaccines](https://elegenbio.com/applications/mrna-prophylactic-vaccines/) - Discover how Elegen helps eliminate bottlenecks in mRNA prophylactic vaccine design, testing, and iteration with ENFINIA IVT Ready DNA, delivered in days.
- [Investors](https://elegenbio.com/company/investors/) - Our Investors Meet our investors
- [Partnering](https://elegenbio.com/company/partnering/) - We’re searching for partners who will be part of a team pushing the boundaries of what's possible in biology. By partnering with Elegen, you gain access to next-gen gene synthesis–and help define the parameters of future products that not only meet research and clinical manufacturing needs but accelerate results.
- [Biosecurity](https://elegenbio.com/company/biosecurity/) - Biosecurity Learn about our biosecurity Your Sequence Information is Secure and Confidential We are a member of the International Gene Synthesis Consortium (IGSC) and follow their Screening Framework Guidance in our application of the Harmonized Screening Protocol to prevent the misuse of synthetic DNA. Elegen screens the sequences of DNA ordered by its customers to
- [Webinar - Drug Discovery World - Where are the breakthroughs in mRNA drug discovery and development](https://elegenbio.com/resources/videos/webinar-drug-discovery-world-where-are-the-breakthroughs-in-mrna-drug-discovery-development/) - Matthew Hill, Elegen CEO, discusses supply bottlenecks in mRNA drug development and how Elegen uses innovative cell-free DNA synthesis platforms to supply long, complex, NGS-verified, dsDNA.
- [Matthew Hill, Founder and CEO of Elegen joins guest panel at SynbioBeta 2023 to discuss advances needed to unlock DNA synthesis.](https://elegenbio.com/resources/videos/matthew-hill-founder-and-ceo-of-elegen-joins-guest-panel-at-synbiobeta-2023-to-discuss-advances-needed-to-unlock-dna-synthesis/) - Representatives from Elegen, Strand Therapeutics, Senti Bio, and other biotech powerhouses discuss how a better solution for DNA synthesis will enable synthetic biologists to realize the promise of programmable biology.
- [Matthew Hill, Making The Dream Of Synthetic Biology A Reality, Panel Discussion at BIO2023](https://elegenbio.com/resources/videos/matthew-hill-making-the-dream-of-synthetic-biology-a-reality-panel-discussion-at-bio2023-2/) - Back to All Videos Matthew Hill, Making The Dream Of Synthetic Biology A Reality, Panel Discussion at BIO2023 Recorded at the BIO2023 International Convention, Julianna LeMieux, Deputy Editor and Chief of Genetic Engineering News moderates this discussion about the impacts and future of DNA synthesis and synthetic biology with industry thought leaders Matthew Hill, Founder
- [Matthew Hill, Founder and CEO of Elegen at Synbiobeta 2023](https://elegenbio.com/resources/videos/matthew-hill-founder-and-ceo-of-elegen-at-synbiobeta-2023/) - Back to All Videos Matthew Hill, Founder and CEO of Elegen at Synbiobeta 2023 Update on the latest advancements of Elegen’s products and technology, presented at the Synbiobeta 2023 conference, by Matthew Hill, Founder and CEO.
- [Company](https://elegenbio.com/company/) - Company About Elegen Elegen Team Learn more Investors Learn more Partnering Learn more Events Learn more Biosecurity Learn more Privacy Policy Learn more Contact Us Learn more Careers Learn more
- [Webinar - ENFINIA™ Cell-free Synthesized DNA for Rapid Protein Expression and Screening in the myTXTL® Cell-free System](https://elegenbio.com/resources/videos/webinar-elegen-mytxtl-ddw/) - Dr. Galit Meshulam-Simon, Elegen, and Dr. Ben Steil, Daicel Arbor Biosciences discuss how combining ability to synthesize high-quality linear DNA and successful expression in cell-free systems enable rapid, efficient and streamlined in vitro workflows.
- [Video: Watch DDW CGT Showcase](https://elegenbio.com/resources/videos/ddw-cgt-showcase-2024/) - Back to All Videos DDW Cell and Gene Therapy Showcase
- [Watch Video - GEN ALDE Webinar](https://elegenbio.com/resources/videos/watch-video-gen-alde-webinar/) - Back to All Videos Webinar - GEN - AI-assisted Direct Evolution with Caltech and Elegen
- [Watch Video - Rapid Synthesis of Full-Length High-Complexity Clonal Genes](https://elegenbio.com/resources/videos/watch-video-gen-rapid-synthesis-of-full-length-high-complexity-clonal-genes/) - Back to All Videos Webinar - GEN - Rapid Synthesis of Full-Length High-Complexity Clonal Genes
- [Watch Video - Using ENFINIA™ Cell-free Synthesized DNA for Rapid Protein Expression and Screening in the myTXTL® Cell-free System](https://elegenbio.com/resources/videos/1460-2/) - Back to All Videos Webinar - Using ENFINIA™ Cell-free Synthesized DNA for Rapid Protein Expression and Screening in the myTXTL® Cell-free System
- [Webinar - Faster Paths to mRNA Therapeutics with IVT Ready DNA](https://elegenbio.com/resources/videos/webinar-faster-paths-to-mrna-therapeutics-with-ivt-ready-dna/) - Back to All Videos Webinar - Faster Paths to mRNA Therapeutics with IVT Ready DNA The rise of mRNA technology has created new possibilities for developing vaccines, cancer therapies, and treatments for genetic diseases. However, producing mRNA still faces challenges, especially when preparing DNA templates for in vitro transcription (IVT). Traditional plasmid-based methods are often
- [Video - Faster Paths to mRNA Therapeutics with IVT Ready DNA](https://elegenbio.com/resources/videos/video-faster-paths-to-mrna-therapeutics-with-ivt-ready-dna/) - Delivered as fast as 7 days and up to 7kb in length, ENFINIA Linear DNA is produced by cell-free DNA production technology and provides unprecedented speed, length, and quality.
- [Video - Introducing ENFINIA DNA: Rapid, Cell Free, Long, Complex, NGS-verified, DNA synthesis](https://elegenbio.com/resources/videos/video-introducing-enfinia-dna-rapid-cell-free-long-complex-ngs-verified-dna-synthesis/) - Delivered as fast as 7 days and up to 7kb in length, ENFINIA Linear DNA is produced by cell-free DNA production technology and provides unprecedented speed, length, and quality.
- [Webinar - Rapid Synthesis of Full-Length High-Complexity Clonal Genes](https://elegenbio.com/resources/videos/webinar-gen-enfinia-plasmid-dna-synthesis/) - Traditional methods of constructing plasmids with intricate genes can be time-consuming and error prone. This webinar discusses DNA synthesis advancements that enable the rapid and accurate creation of long, complex plasmids.
- [DDW Cell and Gene Therapy Showcase](https://elegenbio.com/resources/videos/webinar-ddw-2024-cgt-showcase/) - Pre-recorded presentations that cover how next-generation gene synthesis technology is helping to advance areas, like TCR engineering, CAR-T therapies, gene editing, and mRNA vaccines.
- [Webinar - Enhancing Protein Engineering with Active Learning-Assisted Directed Evolution](https://elegenbio.com/resources/videos/webinar-assisted-directed-evolution-caltech-and-elegen/) - Learn about the basics behind ALDE, its applications and how next-generation DNA synthesis supports research surrounding it. Presented by Ravi Goel Lal from Caltech and Dr. Galit Meshulam-Simon, Associate Director of Commercial Applications at Elegen
- [Webinar - BioInsights - Accelerate CGT development with cell-free synthesis of long, complex synthetic DNA](https://elegenbio.com/resources/videos/webinar-bioinsights-accelerate-cgt-development-with-cell-free-synthesis-of-long-complex-synthetic-dna/) - Learn about improvements Elegen has made to enable the cell-free synthesis of ENFINIA™ DNA constructs, which are commonly used in cell and gene therapies.
- [Application Note: Accelerated CRISPR-Cas Characterization with ENFINIA Linear DNA Templates and Cell-Free TXTL](https://elegenbio.com/resources/literature/application-note-accelerated-crispr-cas-characterization-with-enfinia-linear-dna-templates-and-cell-free-txtl/) - This application note demonstrates the capability of cell-free linear DNA in gene editing applications that typically require plasmid DNA.
- [Download GEN mRNA eBook: Advancing mRNA Vaccine and Therapy Development - July 2024](https://elegenbio.com/resources/literature/download-gen-mrna-ebook-advancing-mrna-vaccine-and-therapy-development-july-2024/) - Back to All Literautre GEN eBook: Next-Gen Gene Synthesis Using Cell-Free Cloning [pdf-embedder url="https://elegenbio.com/wp-content/uploads/2025/03/GEN_Elegen_Next-Gen-Gene-Synthesis-Using-Cell-Free-Cloning_FINAL.pdf" download="on"]
- [ENFINIA™ DNA 2025 Pricing Update](https://elegenbio.com/resources/literature/enfinia-dna-2025-pricing-update/) - Elegen announces new pricing across ENFINIA DNA products, now as low as $0.15 per base pair. The price reduction allows researchers to screen, optimize, and gain insights faster
- [Application Note: Rapid Clonal Gene Synthesis of Long, Complex Biosynthetic Pathways](https://elegenbio.com/resources/literature/application-note-rapid-clonal-gene-synthesis-of-long-complex-biosynthetic-pathways/) - Learn about the advantages of ENFINIA™ Plasmid DNA. In this application note, we demonstrate the advantages of ENFINIA Plasmid DNA using the β-carotene and lycopene biosynthetic pathways to assemble and clone complex sequences.
- [Application Note - Rapid Cell-Free Protein Expression with ENFINIA™ Linear DNA](https://elegenbio.com/resources/literature/application-note-rapid-cell-free-protein-expression-with-enfinia-linear-dna/) - This application note demonstrates that ENFINIA Linear DNA performs comparably to plasmid DNA in the myTXTL Pro Cell-Free Expression Kit from Daicel Arbor Biosciences.
- [Download DDN Turbocharging mRNA Vaccine Development Poster](https://elegenbio.com/resources/literature/download-ddn-turbocharging-mrna-template-development-poster-8-2024/) - Back to All Literature DDN Poster: Turbocharging mRNA Vaccine Development with Cell-free DNA Synthesis [pdf-embedder url="https://elegenbio.com/wp-content/uploads/2025/04/Poster-69605-DDN-Elegen-DNA-Synthesis-Poster_Final.pdf" download="on"]
- [View Webinar - Accelerated Protein Screening with ENFINIA Linear DNA and GeneFrontier’s Cell-Free PUREfrex](https://elegenbio.com/resources/videos/view-webinar-accelerated-protein-screening-with-enfinia-linear-dna-and-genefrontiers-cell-free-purefrex/) - Delivered as fast as 7 days and up to 7kb in length, ENFINIA Linear DNA is produced by cell-free DNA production technology and provides unprecedented speed, length, and quality.
- [Webinar - Accelerated Protein Screening with ENFINIA Linear DNA and GeneFrontier’s Cell-Free PUREfrex](https://elegenbio.com/resources/videos/webinar-accelerated-protein-screening-with-enfinia-linear-dna-and-genefrontiers-cell-free-purefrex/) - In this GEN webinar, our expert speakers will present a case study demonstrating the exceptional properties and high-fidelity performance of ENFINIA Linear DNA as evaluated in GeneFrontier’s cell-free protein synthesis PUREfrex® system. These results showcase ENFINIA’s outperformance in terms of DNA purity, transcription efficiency, and robust protein expression for various constructs. Originally aired Wednesday October 8th 2025 aT 8A PDT.
- [Application Note: Linear DNA Templates Drive Rapid Cell-Free Protein Expression](https://elegenbio.com/resources/literature/application-note-linear-dna-templates-drive-rapid-cell-free-protein-expression/) - Back to All Literature Application Note - Rapid Cell-Free Protein Expression with ENFINIA™ Linear DNA Cell-free transcription-translation (TXTL) systems are used for rapid and flexible protein expression. Traditionally, plasmid DNA has been used as the template for protein expression in cell-free systems, but this requires time-consuming cloning steps.ENFINIA™ Linear DNA templates, synthesized by Elegen, offer
- [Download DNA Buyer's Guide - Next Generation Cell-Free Synthesis](https://elegenbio.com/resources/literature/download-dna-buyers-guide-next-generation-cell-free-synthesis/) - Back to All Literautre DNA Buyer's Guide - Next Generation Cell-Free Synthesis This guide contains a detailed comparison of more than 10 industry-leading gene synthesis vendors, including key performance metrics such as error rate, turnaround time, synthesis cost, and maximum DNA length. [pdf-embedder url="https://elegenbio.com/wp-content/uploads/2025/03/2024-ebook-Elegen-DNA-Buyers-Guide_FINAL.pdf" download="on"]
- [Download Enzymatic Addition of Poly-A Tail to Linear Synthetic DNA to Accelerate in vitro Transcription-mediated mRNA Synthesis](https://elegenbio.com/resources/literature/enzymatic-addition-of-poly-a-tail-to-linear-synthetic-dna-to-accelerate-in-vitro-transcription-mediated-mrna-synthesis/) - Back to All Literature Enzymatic Addition of Poly-A Tail to Linear Synthetic DNA to Accelerate in vitro Transcription-mediated mRNA Synthesis Commercial-scale mRNA synthesis for the development and production of vaccines typically involves in vitro transcription (IVT) of a synthetic DNA template comprised of an antigen sequence and several recognition sequences including a capping region, untranslated
- [Download App Note: Rapid Cell-Free Protein Expression with ENFINIA™ Linear DNA](https://elegenbio.com/resources/literature/application-note-rapid-cell-free-protein-expression-with-enfinia-linear-dna-2/) - Back to All Literature Application Note: Rapid Cell-Free Protein Expression with ENFINIA™ Linear DNA Here we demonstrate that ENFINIA Linear DNA templates, synthesized by Elegen, are functional in cell-free TXTL systems and drive reporter gene expression at levels comparable to plasmid DNA templates. [pdf-embedder url="https://elegenbio.com/wp-content/uploads/2025/03/AppNote-ENFINIA-Linear-DNA-Templates-Drive-Rapid-Cell-Free-Protein-Expression_Final.pdf"]
- [Poster – DDN – Turbocharging mRNA Template Development](https://elegenbio.com/resources/literature/poster-ddn-turbocharging-mrna-template-development/) - How advanced cell-free gene synthesis technology offers a rapid, reliable way to expedite mRNA synthesis and lifesaving vaccine and therapy development.
- [eBook - GEN - Next-Gen Gene Synthesis Using Cell-Free Cloning](https://elegenbio.com/resources/literature/ebook-gen-next-gen-gene-synthesis-using-cell-free-cloning/) - This new eBook explores the cutting-edge world of mRNA technology and its potential to revolutionize medicine, powered by cell-free cloning.
- [Application Note: Minimizing the Risk of Impurities Derived from PCR](https://elegenbio.com/resources/literature/download-application-note-minimizing-the-risk-of-impurities-derived-from-pcr/) - This application note is a comparative study between two synthetic gene fragment providers. The results demonstrate ENFINIA™ DNA ability to generate a purer PCR product in comparison to the sequences from Supplier A.
- [View Application Note: Minimizing the Risk of Impurities Derived from PCR](https://elegenbio.com/resources/literature/application-note-minimizing-the-risk-of-impurities-derived-from-pcr/) - Back to All Literature Application Note: Minimizing the Risk of Impurities Derived from PCR Polymerase Chain Reaction (PCR) is a cornerstone technique in molecular biology, crucial for amplifying specific DNA sequences with high fidelity. In applications such as molecular cloning, where the purity of PCR products directly impact downstream success, the quality of synthetic DNA
- [DNA Buyer's Guide - Next Generation Cell-Free Synthesis](https://elegenbio.com/resources/literature/dna-buyers-guide/) - This guide contains a detailed comparison of industry-leading gene synthesis vendors, comparing key metrics (error rate, turnaround time, cost, and length).
- [Download Application Note: Accelerated CRISPR-Cas Characterization with ENFINIA Linear DNA Templates and Cell-Free TXTL](https://elegenbio.com/resources/literature/application-note-accelerated-crispr-cas-characterization-with-enfinia-linear-dna-templates-and-cell-free-txtl-2/) - Back to All Literature Application Note: Accelerated CRISPR-Cas Characterization with ENFINIA™ Linear DNA Templates and Cell-Free TXTL [pdf-embedder url="https://elegenbio.com/wp-content/uploads/2025/04/Application_Note_Accelerated_CRISPR-Cas_Characterization_with_ENFINIA_Linear_DNA_Templates_and_Cell-Free_TXTL_Final.pdf" download="on"] In partnership with
- [Download: Application Note: Rapid Clonal Gene Synthesis of Long, Complex Biosynthetic Pathways](https://elegenbio.com/resources/literature/application-note-rapid-clonal-gene-synthesis-of-long-complex-biosynthetic-pathways-2/) - Back to All Literature Application Note: Rapid Clonal Gene Synthesis of Long, Complex Biosynthetic Pathways [pdf-embedder url="https://elegenbio.com/wp-content/uploads/2025/04/App-Note_-Rapid-Clonal-Gene-Synthesis-of-Long-Complex-Biosynthetic-Pathways_FINAL.pdf" download="on"]
- [Download DDN Turbocharging mRNA Template Development Poster 8-2024](https://elegenbio.com/resources/literature/download-wheres-your-dna/) - Back to All Literature Download: Where's Your DNA? Poster [pdf-embedder url="https://elegenbio.com/wp-content/uploads/2025/05/Waldo-Poster_WEB.pdf" download="on"]
- [Application Note: Using ENFINIA™ Linear DNA in Gibson Assembly Reactions](https://elegenbio.com/resources/literature/application-note-using-enfinia-linear-dna-in-gibson-assembly-reactions/) - In this application note, it is demonstrated that ENFINIA Linear DNA can be used directly in Gibson Assembly reactions without prior adapter removal. Learn how this reduces time and cost.
- [Download DDW In Focus eReport - Cell Therapy (beyond CAR-T) and Opportunities for New Medicines](https://elegenbio.com/resources/literature/download_ddw-in-focus-ereport-cell-therapy-beyond-car-t-and-opportunities-for-new-medicines/) - Presented by Drug Discovery World, this eReport explores the cell therapy market and its expected significant growth in the next five years. Download now to gain an understanding of the current market and the areas of greatest commercial potential for the future.
- [pAAV2-hSyn-AMP Standard Vector Info Sheet](https://elegenbio.com/resources/literature/paav2-hsyn-amp-standard-vector-info-sheet/) - pAAV2-hSyn-AMP Standard Vector Info Sheet
- [psaRNA-AMP Standard Vector Info Sheet](https://elegenbio.com/resources/literature/psarna-amp-standard-vector-info-sheet/) - psaRNA-AMP Standard Vector Info Sheet
- [pBR322-AMP Standard Vector Info Sheet](https://elegenbio.com/resources/literature/pbr322-amp-standard-vector-info-sheet/) - pBR322-AMP Standard Vector Info Sheet
- [pUC19-AMP Standard Vector Info Sheet](https://elegenbio.com/resources/literature/puc19-amp-standard-vector-info-sheet/) - pUC19-AMP Standard Vector Info Sheet
- [Amplification and Cloning Guide](https://elegenbio.com/resources/literature/amplification-and-cloning-guide/) - Recommendations for amplification and cloning ENFINIA Linear DNA, such as resuspending DNA in molecular grade water or TE buffer.
- [Ordering ENFINIA™ DNA : Frequently Asked Questions](https://elegenbio.com/resources/literature/ordering-enfinia-dna-frequently-asked-questions/) - Commonly asked questions regarding ordering ENFINIA DNA, such as DNA sequence limitations, per-base cost, minimum order size, and how to order.
- [High Yield Linear Synthesis Options](https://elegenbio.com/resources/literature/high-yield-linear-synthesis-options/) - High yield synthesis options for ENFINIA Linear DNA. Each sequence synthesized is NGS-verified before shipment
- [Flyer - High Complexity DNA Synthesis](https://elegenbio.com/resources/literature/flyer-high-complexity-dna-synthesis/) - Learn more about Elegen’s superior ability to produce high-complexity DNA sequences that conventional methods struggle with using a novel assembly method.
- [Download - How We Make 7kb in 6 Days](https://elegenbio.com/resources/literature/how-we-make-7kb-in-6-days/) - Learn how Elegen creates linear DNA up to 7kb in length in 6 business days without conventional cell-based cloning, using patented cell-free cloning technology.
- [Download Application Note - Linear DNA Templates Drive Rapid Cell-Free Protein Expression](https://elegenbio.com/resources/literature/download-application-note-linear-dna-templates-drive-rapid-cell-free-protein-expression/) - Back to All Literature Rapid Cell-Free Protein Expression with ENFINIA™ Linear DNA Elegen [pdf-embedder url="https://elegenbio.com/wp-content/uploads/2025/03/AppNote-ENFINIA-Linear-DNA-Templates-Drive-Rapid-Cell-Free-Protein-Expression_Final.pdf" download="on"]
- [pET28 XbaI XhoI Standard Vector Info Sheet](https://elegenbio.com/resources/literature/pet28_xbai_xhoi-standard-vector-info-sheet/) - pAAV2-hSyn-AMP Standard Vector Info Sheet
- [pET28 EcoRI HindIII Standard Vector Info Sheet](https://elegenbio.com/resources/literature/pet28_ecori_hindiii-standard-vector-info-sheet/) - pAAV2-hSyn-AMP Standard Vector Info Sheet
- [ENFINIA™ PLASMID DNA: Frequently Asked Questions](https://elegenbio.com/resources/literature/enfinia-plasmid-dna-frequently-asked-questions/) - Back to All Literature ENFINIA™ Plasmid DNA: Frequently Asked Questions [pdf-embedder url="https://elegenbio.com/wp-content/uploads/2025/06/Elegen-ENFINICA-Plasmid-DNA-FAQ_3.4.26.pdf" download="on"]
- [DDW In Focus eReport - Cell Therapy (Beyond Car-T) and Opportunities for New Medicines](https://elegenbio.com/resources/literature/ddw-in-focus-ereport_may25_cell-therapies_elegen-pdf/) - High yield synthesis options for ENFINIA Linear DNA. Each sequence synthesized is NGS-verified before shipment
- [Specifications and Submission Guidelines](https://elegenbio.com/resources/literature/sequence-submission-acceptance-criteria/) - Sequence submission acceptance criteria for ENFINIA™ Linear DNA
- [ENFINIA™ DNA - A New Class of DNA](https://elegenbio.com/resources/literature/enfinia-dna-a-new-class-of-dna/) - Learn more about how Elegen's cell-free gene synthesis technology offers rapid, scalable, and high-fidelity DNA solutions in this brochure.
- [Download - Introduction to ENFINIA™ Linear DNA Flyer](https://elegenbio.com/resources/literature/download-introduction-to-enfinia-linear-dna-flyer/) - How ENFINIA DNA expands limitations with high-complexity synthesis and saves you time in applications like mRNA vaccines and cell & gene therapy
- [ENFINA Plasmid DNA Specifications and Submission Guidelines](https://elegenbio.com/resources/literature/enfina-plasmid-dna-specifications-and-submission-guidelines/) - Sequence submission acceptance criteria for ENFINIA™ Plasmid DNA
- [pAAV2-AMP Standard Vector Info Sheet](https://elegenbio.com/resources/literature/paav2-amp-standard-vector-info-sheet/) - pAAV2-AMP Standard Vector Info Sheet
- [pAAV2-CAG-AMP Standard Vector Info Sheet](https://elegenbio.com/resources/literature/paav2-cag-amp-standard-vector-info-sheet/) - pAAV2-CAG-AMP Standard Vector Info Sheet
- [pAAV2-CMV-AMP Standard Vector Info Sheet](https://elegenbio.com/resources/literature/paav2-cmv-amp-standard-vector-info-sheet/) - pAAV2-CMV-AMP Standard Vector Info Sheet
- [Download - High Complexity Flyer](https://elegenbio.com/resources/literature/download-high-complexity-flyer/) - Back to All Literature High Complexity DNA Synthesis Flyer [pdf-embedder url="https://elegenbio.com/wp-content/uploads/2025/04/High-Complexity-Synthesis-Flyer_Final.pdf"]
- [Download Application Note: Using ENFINIA™ Linear DNA in Gibson Assembly Reactions](https://elegenbio.com/resources/literature/download-application-note-using-enfinia-linear-dna-in-gibson-assembly-reactions/) - Save time by using ENFINIA Linear DNA directly in Gibson Assembly reactions. Learn more in this app note from Elegen.
- [pcDNA3.1  Standard Vector Info Sheet](https://elegenbio.com/resources/literature/pcdna3-1-standard-vector-info-sheet/) - Back to All Literature pcDNA3.1 Standard Vector Info Sheet [pdf-embedder url="https://elegenbio.com/wp-content/uploads/2025/06/IS-00562_ENFINIA-Plasmid-Standard-Vector-Info-Sheet_pcDNA3.1_R2.pdf" download="on"]
- [Download Whitepaper - ENFINIA IVT Ready DNA is a High-Performance Template for in vitro transcription​](https://elegenbio.com/resources/literature/download-whitepaper-enfinia-ivt-ready-dna-is-a-high-performance-template-for-in-vitro-transcription/) - This whitepaper compares ENFINIA™ IVT Ready DNA, a cell-free DNA synthesis platform, against conventional plasmid-based templates for producing messenger RNA (mRNA).
- [Download Whitepaper - ENFINIA IVT Ready DNA - Cell-Free Linear DNA Templates for mRNA Synthesis](https://elegenbio.com/resources/literature/download-whitepaper-enfinia-ivt-ready-dna-cell-free-linear-dna-templates-for-mrna-synthesis/) - This study compares ENFINIA IVT Ready DNA to linearized plasmid DNA as templates for IVT by evaluating template quality, resulting mRNA yield and quality, and the expression level of transcribed eGFP in HeLa mammalian cells. The findings validate use of IVT-ready DNA as a reliable, superior alternative to plasmid-based approaches, overcoming sequence heterogeneity and host cell contamination associated with plasmid-derived DNA templates.
- [Case Study: Accelerating the Development of Designer Polyketides](https://elegenbio.com/resources/case-studies/download-univeristy-of-texas-austin-case-study/) - Learn how researchers at UT Austin use Elegen's synthetic DNA for in vivo biosynthesis of designer polyketides.
- [Case Study: Accelerating Streptococcus pneumoniae pathogenicity study at University of Colorado Anschutz](https://elegenbio.com/resources/case-studies/university-of-colorado-anschutz/) - Labs at the University of Colorado Anschutz Medical Campus were inevitably saved by Elegen's ability to quickly synthesize DNA after running out of time when using another gene synthesis provider.
- [Case Study: Access to High-Complexity DNA Drives Advanced Therapy Production with Asimov](https://elegenbio.com/resources/case-studies/asimov-case-study-access-to-high-complexity-dna-drives-advanced-therapy-production/) - Learn how Elegen enables the immediate use of DNA fragments in plasmid assembly by providing DNA fragments with a higher level of accuracy and length to streamline processes for Asimov.
- [Download Case Study – Asimov – Access to High-Complexity DNA Drives Advanced Therapy Production](https://elegenbio.com/resources/case-studies/download-case-study-asimov-access-to-high-complexity-dna-drives-advanced-therapy-production/) - Back to All Literature Rapid, Reliable Access to High-Complexity DNA Drives Advanced Therapy Production [pdf-embedder url="https://elegenbio.com/wp-content/uploads/2025/04/Elegen_Asimov-Case-Study_FINAL.pdf"]
- [Download CU Anschutz Case Study: Delivering the Essential Knockout to Explore Sortase-A Functionality](https://elegenbio.com/resources/case-studies/case-study-cu-anschutz/) - Back to All Literature Delivering the Essential Knockout to Explore Sortase-A Functionality University of Colorado - Anschutz Medical Campus [pdf-embedder url="https://elegenbio.com/wp-content/uploads/2025/04/Elegen_Anschutz_Case-Study_Final.pdf"]
- [Download Case Study – Asimov – Access to High-Complexity DNA Drives Advanced Therapy Production](https://elegenbio.com/resources/case-studies/download-case-study-asimov-access-to-high-complexity-dna-drives-advanced-therapy-production-2/) - Back to All Literature Rapid, Reliable Access to High-Complexity DNA Drives Advanced Therapy Production Elegen [pdf-embedder url="https://elegenbio.com/wp-content/uploads/2025/04/Elegen_Asimov-Case-Study_FINAL.pdf"]
- [Download Application Note: Validation of ENFINIA Plasmid DNA Production](https://elegenbio.com/resources/literature/download-application-note-validation-of-enfinia-plasmid-dna-production/) - App Note : Validates the performance of Elegen’s ENFINIA™ Plasmid DNA synthesis technology, which aims to overcome limitations in traditional gene synthesis.
- [Download Case Study: Accelerating the Development of Designer Polyketides](https://elegenbio.com/resources/case-studies/accelerating-the-development-of-designer-polyketides/) - Save time by using ENFINIA Linear DNA directly in Gibson Assembly reactions. Learn more in this app note from Elegen.
- [Download Case Study: Case Study: Accelerate Functional Screening with ENFINIA™ Linear DNA and GeneFrontier’s Cell-Free Protein Synthesis System](https://elegenbio.com/resources/case-studies/download-case-study-case-study-accelerate-functional-screening-with-enfinia-linear-dna-and-genefrontiers-cell-free-protein-synthesis-system/) - The GeneFrontier case study demonstrates how Elegen's ENFINIA™ Linear DNA accelerates functional screening by providing rapid and reliable synthesis of long, complex linear DNA
- [Case Study: Accelerate Functional Screening with ENFINIA™ Linear DNA and GeneFrontier’s Cell-Free Protein Synthesis System](https://elegenbio.com/resources/case-studies/case-study-accelerate-functional-screening-with-enfinia-linear-dna-and-genefrontiers-cell-free-protein-synthesis-system/) - The GeneFrontier case study demonstrates how Elegen's ENFINIA™ Linear DNA accelerates functional screening by providing rapid and reliable synthesis of long, complex linear DNA
- [Case Study: Enabling CDMOs to Fast- Track mRNA Discovery with ENFINIA™ IVT Ready DNA](https://elegenbio.com/resources/case-studies/case-study-enabling-cdmos-to-fast-track-mrna-discovery-with-enfinia-ivt-ready-dna/) - Vernal, a leading CDMO, directly compared mRNA produced from ENFINIA IVT Ready DNA against mRNA from Vernal's standard linearized plasmid DNA. Key quality attributes such as RNA yield, integrity, dsRNA content, capping efficiency, and poly(A) tail length were assessed.
- [Download Case Study: Enabling CDMOs to Fast- Track mRNA Discovery with ENFINIA™ IVT Ready DNA](https://elegenbio.com/resources/case-studies/download-case-study-enabling-cdmos-to-fast-track-mrna-discovery-with-enfinia-ivt-ready-dna/) - Vernal evaluated Elegen’s ENFINIA™ IVT Ready DNA, a cell-free, linear DNA template, as a faster alternative to linearized plasmids.
- [Elegen Pioneers Long DNA Subindustry with CEO, Matt Hill](https://elegenbio.com/news/elegen-pioneers-long-dna-subindustry-with-ceo-matt-hill/) - Mendelspod Podcast sits down with Matthew Hill, Elegen CEO and Founder, for a short interview
- [Elegen Launches ENFINIA™ DNA](https://elegenbio.com/news/elegen-launches-enfinia-dna/) - March 21, 2023 - Elegen launches new product that delivers up to 7kb of high-accuracy DNA and provides unparalleled combination of speed, length, and quality.
- [Enabling the Synthetic Biology Revolution](https://elegenbio.com/news/enabling-the-synthetic-biology-revolution/) - The Elegen team knows when barriers to the fast, accurate, and low-cost synthesis of long DNA fall, biotechnology will be driven by the design-build-test-learn cycle
- [Resources](https://elegenbio.com/resources/) - Resources Learn more about our next-generation synthesis capabilities. Case Studies Learn more Literature Learn more Videos Learn more Knowledgebase Learn more
- [CELL-FREE GENE SYNTHESIS - Eliminating Critical Bottlenecks in Genetic Medicine Development](https://elegenbio.com/news/cell-free-gene-synthesis-eliminating-critical-bottlenecks-in-genetic-medicine-development/) - This article explores the market trends, challenges, and opportunities new DNA production technologies provide to accelerate genetic advances in healthcare.
- [Integrated DNA Technologies and Elegen Partner to Revolutionize Long DNA Synthesis Market](https://elegenbio.com/news/integrated-dna-technologies-and-elegen-partner-to-revolutionize-long-dna-synthesis-market/) - Strategic partnership marks launch of early access program offering rapid, long, clonal gene synthesis and high-complexity genes up to 15 kb.
- [The World's Most Innovative Companies of 2025](https://elegenbio.com/news/the-worlds-most-innovative-companies-of-2025/) - Elegen ranked #8 on list of most innovative companies with between 51 and 200 employees for 2025.
- [2025 Pricing Announcement](https://elegenbio.com/news/enfinia-pricing-announcement/) - New Lower Pricing Available. Linear DNA Synthesis starting at $0.15/bp. No Cloning, No Foundry. Eliminate the limitations of traditional cloning-based methods.
- [Elegen’s Cell-Free DNA Synthesis Speeds the Discovery and Development of Genetic Medicines](https://elegenbio.com/news/elegens-cell-free-dna-synthesis-speeds-the-discovery-and-development-of-genetic-medicines/) - News The latest updates and news Back to All News Elegen’s Cell-Free DNA Synthesis Speeds the Discovery and Development of Genetic Medicines SOURCE: Big4Bio APR 29, 2024 Marc Unger, Chief Scientific Officer, talks about Elegen’s cell-free DNA synthesis technology ENFINIA™ DNA, how it changes the paradigm of discovery and development for genetic medicines, and the
- [Elegen Expands ENFINIA™ Platform with IVT Ready DNA to Streamline RNA Therapeutics Development](https://elegenbio.com/news/elegen_expands_enfinia_platform_with_ivt_ready_dna_to_streamline_rna_therapeutics_development/) - News The latest updates and news Back to All News Elegen Expands ENFINIA™ Platform with IVT Ready DNA to Streamline RNA Therapeutics Development SOURCE: Business Wire MAY 7, 2025 Elegen’s early access program for ENFINIA IVT Ready DNA offers full-length, high-complexity, high-accuracy linear DNA with a long poly(A) tail, manufactured cell-free and delivered in as
- [Cell-Free DNA: Accelerating Next-Gen mRNA Therapeutics](https://elegenbio.com/news/cell_free_dna_accelerating_next_gen_mrna_therapeutics/) - News The latest updates and news Back to All News Cell-Free DNA: Accelerating Next-Gen mRNA Therapeutics SOURCE: The Scientist MAY 15, 2025 AI-driven design + rapid, cell-free DNA synthesis are turning mRNA into a scalable solution for vaccines, cancer treatments, & personalized genetic therapies. [pdf-embedder url="/wp-content/uploads/2025/05/Cell-Free-DNA-Accelerating-Next-Gen-mRNA-Therapeutics_WEB.pdf"]
- [Elegen Expands ENFINIA™ Platform with IVT Ready DNA to Streamline RNA Therapeutics Development](https://elegenbio.com/news/elegen-expands-enfinia-platform-with-ivt-ready-dna-to-streamline-rna-therapeutics-development/) - News The latest updates and news Back to All News Elegen Expands ENFINIA™ Platform with IVT Ready DNA to Streamline RNA Therapeutics Development MAY 7, 2025 ENFINIA IVT Ready DNA offers full-length, high-complexity, high-accuracy linear DNA with a long poly(A) tail, manufactured cell-free and delivered in as few as 10 days, ready for immediate use.
- [Elegen and Nutcracker Therapeutics to Pilot First Fully Cell-Free Manufacturing Process for RNA-based Personalized Cancer Therapeutics](https://elegenbio.com/news/elegen-and-nutcracker-therapeutics-to-pilot-first-fully-cell-free-manufacturing-process-for-rna-based-personalized-cancer-therapeutics/) - Elegen and Nutcracker Therapeutics announced the launch of a pilot program to demonstrate the industry’s first fully synthetic, cell-free manufacturing platform for RNA-based personalized cancer therapeutics.
- [The Top 25 Biotechnology Companies of 2024](https://elegenbio.com/news/the-top-25-biotechnology-companies-of-2024/) - How Elegen is expediting DNA sequencing. Elegen has been named among the Top 25 Biotechnology Companies of 2024 by the Healthcare Technology Report
- [Is Synthetic Plasmid DNA One of the Solutions for Meeting Growing Demand for Next-Gen Therapies?](https://elegenbio.com/news/is-synthetic-plasmid-dna-one-of-the-solutions-for-meeting-growing-demand-for-next-gen-therapies/) - How cell-free routes to synthetic DNA may address problems with the development of next-generation vaccines and therapies.
- [Improving Cell and Gene Therapy Process Development](https://elegenbio.com/news/improving-cell-and-gene-therapy-process-development/) - How Elegen is addressing bottlenecks within CGT process development processes synthesis bottleneck with its cell-free DNA synthesis process.
- [Health and Medicine News: Elegen Partners with GSK](https://elegenbio.com/news/health-and-medicine-news-elegen-partners-with-gsk/) - Elegen and GSK collaborate to focus on therapeutics and vaccines, CEO Matt Hill sits down with SBB to discuss how the nucleic acid therapeutics space has evolved post-COVID.
- [Life Science Success Podcast: Cell-free DNA Synthesis of Industry Leading Long and Complex DNA](https://elegenbio.com/news/life-science-success-podcast-cell-free-dna-synthesis-of-industry-leading-long-and-complex-dna/) - Elegen CEO, Matt Hill, is interviewed on the Life Science Success show to share how Elegen is revolutionizing synthetic biology workflows with its innovative DNA writing technology.
- [GSK and Elegen Team Up to Develop DNA-Based Medicines and Vaccines](https://elegenbio.com/news/gsk-and-elegen-team-up-to-develop-dna-based-medicines-and-vaccines/) - A multi-year collaboration with Elegen allows GSK to leverage Elegen’s cell-free synthetic DNA production technology.
- [Elegen Announces Multi-year Collaboration and Licensing Agreement with GSK](https://elegenbio.com/news/elegen-announces-multi-year-collaboration-and-licensing-agreement-with-gsk/) - GSK has signed a collaboration & licensing agreement with Elegen to leverage its cell-free DNA manufacturing technology in the development of GSK’s vaccines & medicines.
- [11 Executives, 47 Companies and 108 Products Win 2024 BIG Innovation Award](https://elegenbio.com/news/11-executives-47-companies-and-108-products-win-2024-big-innovation-award/) - Elegen named as one of 47 companies who won the 2024 BIG Innovation Awards by the Business Intelligence Group.
- [Synthetic DNA Advances Will Catalyze the Next Wave of Biotherapeutic Innovation](https://elegenbio.com/news/synthetic-dna-advances-will-catalyze-the-next-wave-of-biotherapeutic-innovation/) - Read about recent innovations in DNA manufacturing that are helping to eliminate critical bottlenecks and bring new therapies to market faster than ever.
- [DNA Writing Technologies Moving Towards Synthetic Genomes](https://elegenbio.com/news/dna-writing-technologies-moving-towards-synthetic-genomes/) - News The latest updates and news Back to All News DNA Writing Technologies Moving Towards Synthetic Genomes SOURCE: Nature Biotechnology OCT 31, 2023 Nature reviews the latest advancements in DNA synthesis and the key challenges the new players like Elegen are quickly overcoming. [pdf-embedder url="/wp-content/uploads/2025/03/DNA-Writing-Technologies-Moving-Towards-Synthetic-Genomes.pdf"]
- [Cell Expansion for Cell Therapies](https://elegenbio.com/news/cell-expansion-for-cell-therapies/) - Biocompare recently published an article on the challenges of scaling cell therapies. Part of this challenge starts upstream in determining the optimal DNA sequence for expansion–a time-consuming, resource-intensive process.
- [Accelerating Biotherapy and Personalized Medicine with Long DNA](https://elegenbio.com/news/accelerating-biotherapy-and-personalized-medicine-with-long-dna/) - Matt Hill, Elegen Founder and CEO, writes about the importance of innovation in DNA synthesis to address critical bottlenecks in biotherapy development.
- [BIOS Builders Episode 15](https://elegenbio.com/news/bios-builders-episode-15/) - Matt Hill, Elegen Founder & CEO, founded Elegen to solve DNA writing and unlock the synthetic biology revolution.
- [Elegen Early Access Partners Receive High-Complexity, Long DNA Sequences in Rapid Time](https://elegenbio.com/news/elegen-early-access-partners-receive-high-complexity-long-dna-sequences-in-rapid-time/) - DNA lengths of 15,000 base pairs and higher represent twice the length of Elegen's recently launched flagship product, ENFINIA DNA, and industry-leading complexity and turnaround time.
- [4 DNA and Genomics Advances Recognized in R&D 100 Awards in 2024](https://elegenbio.com/news/4-dna-and-genomics-advances-recognized-in-rd-100-awards-in-2024/) - This article recognizes Elegen’s ENFINIA DNA technology as one of four DNA and genomics companies that advance the industry in the 2024 R&D 100 Awards.
- [The Top 100 Healthcare Technology Companies of 2024](https://elegenbio.com/news/the-top-100-healthcare-technology-companies-of-2024/) - The Healthcare Technology Report has named Elegen among the Top 100 Healthcare Technology Companies of 2024 amongst other healthcare technology leaders.
- [2024 BioTech Breakthrough Awards Program Celebrates Groundbreaking Biotechnology Innovators Around the World](https://elegenbio.com/news/2024-biotech-breakthrough-awards-program-celebrates-groundbreaking-biotechnology-innovators-around-the-world/) - Elegen’s ENFINIA DNA was named “DNA Synthesis Technology of the Year” by BioTech Breakthrough, a leading independent market intelligence organization that evaluates and recognizes standout life sciences and biotechnology companies around the globe.
- [Exploring the Impact of In Vitro-Transcribed mRNA Impurities on Cellular Responses](https://elegenbio.com/news/exploring-the-impact-of-in-vitro-transcribed-mrna-impurities-on-cellular-responses/) - In this Analytical Chemistry paper, the Genentech group used IVT-ready linearized ENFINIA DNA templates synthesized with 3 sizes of PolyA tail lengths as a starting IVT material for eGFP production to study the length effect on translation efficiency and stability.
- [Accelerating the Pace of Drug R&D with Synthetic Biology](https://elegenbio.com/news/accelerating-the-pace-of-drug-r-and-d-with-synthetic-biology/) - Biocompare spoke with Elegen and other companies who develop critical enabling technologies for drug discovery and development with synthetic biology to gain valuable insight.
- [R&D 100 Winners for 2024 are Announced](https://elegenbio.com/news/rd-100-winners-for-2024-are-announced/) - News The latest updates and news Back to All News R&D 100 Winners for 2024 are Announced SOURCE: R&D World View online AUG 8, 2024 The official 2024 R&D 100 Awards have been announced by R&D World, and Elegen’s ENFINIA DNA is a winner! [pdf-embedder url="/wp-content/uploads/2025/03/rdworldonline.com-RD-100-Winners-for-2024-are-announced.pdf"]
- [R&D 100 Finalists for 2024 are Announced](https://elegenbio.com/news/rd-100-finalists-for-2024-are-announced/) - News The latest updates and news Back to All News R&D 100 Finalists for 2024 are Announced SOURCE: R&D World AUG 1, 2024 Elegen’s ENFINIA DNA is selected as a finalist for the R&D 100 Award. [pdf-embedder url="/wp-content/uploads/2025/03/rdworldonline.com-RD-100-Finalists-for-2024-are-announced.pdf"]
- [Enzymatic DNA Synthesis: Shorter Waits, Longer Strands](https://elegenbio.com/news/enzymatic-dna-synthesis-shorter-waits-longer-strands/) - GEN reviews several DNA manufacturing technologies that have emerged to give synthetic biology companies what they need to revolutionize the life sciences.
- [Elegen Named Among Top Innovative Companies to Watch 2024](https://elegenbio.com/news/elegen-named-among-top-innovative-companies-to-watch-2024/) - BizTech Outlook names as Elegen one of the 2024 Top Innovative Companies to Watch. Read this interview to learn why innovation is its DNA.
- [Elegen Raises $35 Million in Series B to Accelerate Expansion into Clinical Manufacturing](https://elegenbio.com/news/elegen-raises-35-million-in-series-b-to-accelerate-expansion-into-clinical-manufacturing/) - Elegen announces $35M Series B financing led by Triatomic Capital, with additional funding from GSK, who uses Elegen's proprietary cell-free DNA manufacturing technology in development.
- [Elegen’s High-Complexity DNA Synthesis Accelerates the Development of Designer Polyketide Molecules](https://elegenbio.com/news/elegens-high-complexity-dna-synthesis-accelerates-the-development-of-designer-polyketide-molecules/) - Elegen’s ability to synthesize regions of high complexity allows the Keatinge-Clay Lab to move projects with difficult complex sequences from drawing board to incubator in a matter of weeks.
- [Solving Major Bottlenecks in Genetic Medicine & SynBio w DNA Synthesis Innovation](https://elegenbio.com/news/solving-major-bottlenecks-in-genetic-medicine-synbio-w-dna-synthesis-innovation/) - Matt Hill, Elegen CEO, is interviewed by Big4Bio, on Elegen's next big innovation in manufacturing DNA, which bypasses synthetic DNA bottlenecks to accelerate upstream and downstream workflows.
- [Removing Bottlenecks in Synthetic Biology with Cell-Free Synthesis of Long and Complex DNA](https://elegenbio.com/news/removing-bottlenecks-in-synthetic-biology-with-cell-free-synthesis-of-long-and-complex-dna/) - Randy Dyer, VP of Marketing, discusses Elegen's mission to unlock the promise of synthetic biology by eliminating a critical bottleneck in the supply of synthetic DNA.
- [Elegen Launches ENFINIA™ DNA Enhancement for Rapid Synthesis of Highly Complex DNA](https://elegenbio.com/news/elegen-launches-enfinia-dna-enhancement-for-rapid-synthesis-of-highly-complex-dna/) - Elegen’s latest ENFINIA DNA enhancement provides users early access to challenging sequences, including long repeats and STRs, GC-rich promoters, enhancers, terminators, ITRs, LTRs and homopolymers.
- [The World's Most Innovative Companies of 2024](https://elegenbio.com/news/the-worlds-most-innovative-companies-of-2024/) - Elegen is one of Fast Company’s Most Innovative Companies in the small and mighty category.
- [Elegen Cuts Pricing for ENFINIA DNA, Expanding Access to Next-Generation Cell-Free DNA Manufacturing](https://elegenbio.com/news/elegen-cuts-pricing-for-enfinia-dna-expanding-access-to-next-generation-cell-free-dna-manufacturing/) - Elegen Cuts Pricing for ENFINIA™ DNA, Expanding Access to Next-Generation Cell-Free DNA Manufacturing.
- [Pinnacle Awards - 2025 Healthcare Awards Winners](https://elegenbio.com/news/pinnacle-awards-2025-healthcare-awards-winners/) - Elegen recently named the top Innovator in Biotech Solutions from Pinnacle Awards.
- [Technologies Reshaping Vaccine Research and Development](https://elegenbio.com/news/technologies-reshaping-vaccine-research-and-development/) - Biocompare looks at vaccine design, examining considerations from antibody characterization to complex delivery platforms, like LNPs, and use of AI prediction and design.
- [How GSK is Unlocking New Therapies Through Delivery Partnerships](https://elegenbio.com/news/how-gsk-is-unlocking-new-therapies-through-delivery-partnerships/) - News The latest updates and news Back to All News How GSK is Unlocking New Therapies Through Delivery Partnerships SOURCE: PODD Partnership Opportunities in Drug Discovery View online JAN 15, 2025 Steven Roberts, PhD, Director, Scientific Collaborations within GSK Vaccine and Infectious Diseases External Research and Development, discusses what his team really looks for in
- [Elegen Now Ships Plasmids Up to 15 kb in Just 10 Business Days, Bringing Unprecedented Speed to Long DNA Synthesis](https://elegenbio.com/news/elegen-now-ships-plasmids-up-to-15-kb-in-just-10-business-days-bringing-unprecedented-speed-to-long-dna-synthesis/) - Powered by Elegen’s patented cell-free linear DNA synthesis technology, ENFINIA Plasmid DNA slashes lead times from months to just ten days.
- [The Top 50 Healthcare Technology CEOs of 2024](https://elegenbio.com/news/the-top-50-healthcare-technology-ceos-of-2024/) - Elegen CEO Matt Hill has been named #18 in a list of the Top 50 Healthcare Technology CEOs of 2024 by the Healthcare Technology Report.
- [Synthetic DNA as an Alternative to Plasmids](https://elegenbio.com/news/synthetic-dna-as-an-alternative-to-plasmids/) - The synthesis of DNA via the cell-free method is an advanced technology has many benefits versus fermentation. Read more here
- [The Top 25 BioTech and Life Sciences Executives of 2025](https://elegenbio.com/news/the-top-25-biotech-and-life-sciences-executives-of-2025/) - News The latest updates and news Back to All News The Top 25 Biotech and Life Sciences Executives of 2025 SOURCE: The Healthcare Technology Report View online AUG 20, 2025 The Healthcare Technology Report has named Elegen CEO Matt Hill among the Top 25 Biotech and Life Sciences Executives of 2025 who are driving this
- [Cell-Based Gene Therapies: Challenges and Advances in Upstream Manufacturing](https://elegenbio.com/news/cell-based-gene-therapies_challenges-and-advances-in-upstream-manufacturing/) - News The latest updates and news Back to All News Cell-Based Gene Therapies: Challenges and Advances in Upstream Manufacturing SOURCE: Biocompare View online SEP 04, 2025 Biocompare examines advances in upstream manufacturing technologies and processes that enable the development of more efficacious downstream products in less time. [pdf-embedder url="/wp-content/uploads/2025/09/Cell-Based-Gene-Therapies-Challenges-and-Advances-in-Upstream-Manufacturing.pdf"]
- [Elegen Boosts the Speed and Reliability of mRNA Synthesis with Commercial Launch of ENFINIA™ IVT Ready DNA](https://elegenbio.com/news/elegen-boosts-the-speed-and-reliability-of-mrna-synthesis-with-commercial-launch-of-enfinia-ivt-ready-dna/) - News The latest updates and news Back to All News Elegen Boosts the Speed and Reliability of mRNA Synthesis with Commercial Launch of ENFINIA™ IVT Ready DNA SOURCE: Business Wire SEP 09, 2025 Elegen’s cell-free gene synthesis platform delivers full-length, high-complexity linear DNA with encoded poly(A) tails up to three times faster and free from
- [What are the biggest roadblocks still standing in the way of cell and gene therapy commercialization?](https://elegenbio.com/news/what-are-the-biggest-roadblocks-still-standing-in-the-way-of-cell-and-gene-therapy-commercialization/) - News The latest updates and news Back to All News What are the biggest roadblocks still standing in the way of cell and gene therapy commercialization? SOURCE: Pharma’s Almanac View online SEP 02, 2025 Seasoned industry veterans weigh in on the challenges holding back cell and gene therapy development and commercialization. [pdf-embedder url="/wp-content/uploads/2025/09/what-are-the-biggest-roadblocks-still-standing-in-the-way-of-cell-and-gene-therapy-commercialization.pdf"]
- [Press Release: Elegen Offers Early Access to Gen II Cell-Free DNA Platform](https://elegenbio.com/news/press-release-elegen-offers-early-access-to-gen-ii-cell-free-dna-platform/) - Elegen Offers Early Access to Gen II Cell-Free DNA Platform Setting New Standards for Speed, Quality and Cost The company aims to broadly offer DNA from the fully-automated, miniaturized, high-throughput, clinical-ready DNA production platform later next year. - October 27, 2025
- [Search](https://elegenbio.com/search/) - Search Search Search
- [Customer Case Study Program](https://elegenbio.com/customer-case-study-program/) - Share your story about how you are using ENFINIA DNA in your research and how it has improved your workflows. Get $1000 credit towards your next innovation.
- [Privacy Policy](https://elegenbio.com/privacy-policy/) - Privacy Policy UPDATED: OCTOBER 24, 2022 GENERAL STATEMENT Elegen Corp. (“Elegen,” “we,” “us,” or “our”) provides an on-demand DNA synthesis platform. This Privacy Policy is designed to help you understand how we collect, use, process, and share your personal information, and to help you understand and exercise your privacy rights. 1. SCOPE This Privacy Policy
- [Contact Us](https://elegenbio.com/contact-us/) - How can we help? Request info We’re happy to answer your questions about our products, sales, customer support, careers, or investor relations. Please fill out the form and submit, and we will get back to you as soon as we can. * RequiredPlease note that generic email domains (i.e. gmail, yahoo) will not be accepted

## Categories

- [Uncategorized](https://elegenbio.com/literature/uncategorized/)
- [ENFINIA™ Plasmid DNA](https://elegenbio.com/literature/enfinia-plasmid-dna/)
- [ENFINIA™ Linear DNA](https://elegenbio.com/literature/enfinia-linear-dna/)
- [ENFINIA™ IVT Ready DNA](https://elegenbio.com/literature/enfinia-ivt-ready-dna/)

## Tags

- [Plasmid Vectors](https://elegenbio.com/tag/plasmid-vectors/)